Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, cash reserves at Quince Therapeutics Inc fell by 23.83m. Cash Flow from Financing totalled 143.00k or -- of revenues. In addition the company used 18.29m for operations while cash used for investing totalled 5.76m.
Cash flow per share | -1.29 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 1.09 |
---|---|
Tangible book value per share | -0.3426 |
More ▼
Balance sheet in USDView more
Current ratio | 6.15 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.2945 |
---|---|
Total debt/total capital | 0.2275 |
More ▼